The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT06420154 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06420154
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Sjogren's Syndrome Systemic Sclerosis Inflammatory Myopathy ANCA Associated Vasculitis Antiphospholipid Syndrome

Start date: 2024-05-27
Primary completion: 2027-05-27
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.